Reference is made to the announcement by Hofseth BioCare ASA on 16 October 2020 concerning the completion of a private placement with total gross proceeds of approximately NOK 200 million and a contemplated subsequent offering (the "Subsequent Offering").
|Date on which the terms of the Subsequent Offering was announced:||16 October 2020|
|Last day including right:||15 October 2020|
|First day excluding right:||16 October 2020|
|Record date:||19 October 2020|
|EGM date:||On or about 11 November 2020|
|Maximum number of new shares:||4,938,271|
|Subscription price:||NOK 8.10|
|Shall the rights be listed||No|
This information is published in accordance with the requirements of the Continuing Obligations.